摘要
目的分析达格列净联合利拉鲁肽注射液治疗糖尿病肾病(DN)的临床疗效及对蛋白尿的影响。方法选取广安门中医院南区内分泌科2020年1月至2021年1月收治的180例DN患者,根据随机数表法分为两组,对照组(n=90)给予利拉鲁肽治疗,观察组(n=90)给予达格列净联合利拉鲁肽治疗,比较两组临床疗效、肾功能指标、血清炎症指标、不良反应发生率。结果观察组临床总有效率为96.67%,高于对照组的77.78%,差异有统计学意义(P<0.05)。观察组治疗后血清肌酐(Scr)、尿素氮(BUN)、尿蛋白排泄率(UAER)均低于对照组,差异有统计学意义(P<0.05)。观察组治疗后血清C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)均低于对照组,差异有统计学意义(P<0.05)。观察组不良反应总发生率与对照组比较,差异无统计学意义(P>0.05)。结论达格列净联合利拉鲁肽可有效改善DN患者肾功能,抑制机体炎症因子释放,且联合给药不良反应较少。
Objective To analyze the clinical effect of dapagliflozin combined with liraglutide injection on diabetic nephropathy(DN)and its influence on proteinuria.Methods A total of 180 patients with DN admitted to Department of Endocrinology of Guanganmen Traditional Chinese Medicine Hospital South District from January 2020 to January 2021 were randomly divided into two groups.The control group(n=90)was treated with liraglutide,while the observation group(n=90)was treated with dapagliflozin combined with liraglutide.The clinical efficacy,renal function index,serum inflammation index and the incidence of adverse reactions were compared between the two groups.Results The total clinical effective rate of the observation group(96.67%)was higher than that of the control group(77.78%),with statistically significant difference(P<0.05).After treatment,serum creatinine(Scr),blood urea nitrogen(BUN)and urinary albumin excretion rate(UAER)in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).After treatment,serum C-reactive protein(CRP),tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).There was no significant difference in the total incidence of adverse reactions between the observation group and the control group(P>0.05).Conclusion Dapagliflozin combined with liraglutide can effectively improve the renal function of DN patients,and inhibit the release of inflammatory factors,and the adverse reactions of combined administration are less.
作者
秦莉
张秋菊
QIN Li;ZHANG Qiuju(Department of Endocrinology,Guang'anmen Traditional Chinese Medicine Hospital South District,Beijing 102600,China)
出处
《中国医药科学》
2022年第20期78-81,共4页
China Medicine And Pharmacy
关键词
达格列净
利拉鲁肽
糖尿病肾病
临床疗效
Dapagliflozin
Liraglutide
Diabetic nephropathy
Clinical effi cacy
